Orencia
Orencia ingredients
| Active ingredient | Strength |
|---|---|
| Abatacept | 50 mg/.4mL, 250 mg/15mL, 125 mg/mL, 87.5 mg/.7mL |
What Orencia is used for
The FDA lists the approved uses on the official label (below). In the EU, abatacept is approved as Orencia for:
Rheumatoid arthritis Orencia, in combination with methotrexate, is indicated for: the treatment of moderate to severe active rheumatoid arthritis (RA) in adult patients who responded inadequately to previous therapy with one or more disease-modifying anti-rheumatic drugs (DMARDs) including methotrexate (MTX) or a tumour necrosis factor (TNF)-alpha inhibitor. the treatment of highly active and progressive disease in adult patients with rheumatoid arthritis not previously treated with methotrexate. A reduction in the progression of joint damage and improvement of physical function have been demonstrated during combination treatment with abatacept and methotrexate. Psoriatic arthritis Orencia, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis (PsA) in adult patients when the response to previous DMARD therapy including MTX has been…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Orencia
- Generic name
- Abatacept
- Made by
- E.R. Squibb & Sons, L.L.C.
- Forms
- Injection, Powder, Lyophilized, For Solution, Injection, Solution
- Given
- Intravenous, Subcutaneous
- Drug class
- Selective T Cell Costimulation Modulator
- FDA approval
- Biologic licence (BLA) BLA125118
- On the US market since
- 2009
Official information
- Orencia prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Abatacept)
In India
- Abatacept: 1 brand in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Orencia?
Orencia (Abatacept) is a specialist medicine made by E.R. Squibb & Sons, L.L.C., approved by the US FDA.
What are the ingredients of Orencia?
Orencia contains Abatacept (50 mg/.4mL, 250 mg/15mL, 125 mg/mL, 87.5 mg/.7mL).
Is Orencia approved in Europe?
The same active substance is approved in the EU as Orencia.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA